John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cisco
CSCO
|
+$226M |
| 2 |
JPMorgan Chase
JPM
|
+$212M |
| 3 |
TSMC
TSM
|
+$204M |
| 4 |
Occidental Petroleum
OXY
|
+$194M |
| 5 |
Apple
AAPL
|
+$180M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$271M |
| 2 |
Microsoft
MSFT
|
+$267M |
| 3 |
Canadian Pacific Kansas City
CP
|
+$255M |
| 4 |
Thermo Fisher Scientific
TMO
|
+$226M |
| 5 |
Coca-Cola
KO
|
+$225M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.48% |
| 2 | Healthcare | 15.21% |
| 3 | Industrials | 10.23% |
| 4 | Consumer Discretionary | 10.15% |
| 5 | Financials | 9.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1576
Identive
INVE
$70M
| $1.26M | ﹤0.01% |
77,954
+14,948
| +24% | +$287K |
|
1577
RadNet
RDNT
$6.01B
| $1.26M | ﹤0.01% |
+56,364
| New | +$1.38M |
|
|
ATYR
1578
aTyr Pharma
ATYR
$54.2M
| $1.26M | ﹤0.01% |
235,237
-251,756
| -52% | -$1.43M |
|
1579
Donnelley Financial Solutions
DFIN
$1.17B
| $1.26M | ﹤0.01% |
+37,783
| New | +$1.35M |
|
1580
Prosperity Bancshares
PB
$8.71B
| $1.25M | ﹤0.01% |
+18,058
| New | +$1.33M |
|
1581
PUT
NRG Energy
NRG
$24.1B
| $1.25M | ﹤0.01% |
32,600
-3,000
| -8% | -$117K |
|
1582
Destination XL Group
DXLG
$34.8M
| $1.25M | ﹤0.01% |
256,067
+5,010
| +2% | +$24.1K |
|
1583
Rapid7
RPD
$803M
| $1.25M | ﹤0.01% |
11,239
-135,997
| -92% | -$13.7M |
|
1584
Prelude Therapeutics
PRLD
$530M
| $1.25M | ﹤0.01% |
180,412
-102,362
| -36% | -$936K |
|
|
ABST
1585
DELISTED
Absolute Software Corp
ABST
| $1.24M | ﹤0.01% |
146,705
-255,395
| -64% | -$2.16M |
|
1586
Cathay General Bancorp
CATY
$4.13B
| $1.24M | ﹤0.01% |
27,735
-2,886
| -9% | -$133K |
|
1587
Addus HomeCare
ADUS
$2.26B
| $1.24M | ﹤0.01% |
+13,270
| New | +$1.07M |
|
1588
KRONOS Worldwide
KRO
$1.03B
| $1.24M | ﹤0.01% |
79,657
+13,376
| +20% | +$199K |
|
1589
Universal Display
OLED
$4.01B
| $1.24M | ﹤0.01% |
7,400
-21,424
| -74% | -$3.33M |
|
1590
PDF Solutions
PDFS
$1.85B
| $1.23M | ﹤0.01% |
44,106
-76,191
| -63% | -$2.13M |
|
1591
Uranium Energy
UEC
$6.54B
| $1.23M | ﹤0.01% |
267,859
+175,901
| +191% | +$647K |
|
1592
indie Semiconductor
INDI
$835M
| $1.22M | ﹤0.01% |
+156,117
| New | +$1.28M |
|
1593
Globe Life
GL
$13.3B
| $1.22M | ﹤0.01% |
12,103
-7,481
| -38% | -$758K |
|
1594
Citi Trends
CTRN
$563M
| $1.22M | ﹤0.01% |
39,700
+32,000
| +416% | +$1.5M |
|
|
GATO
1595
DELISTED
Gatos Silver, Inc.
GATO
| $1.22M | ﹤0.01% |
281,273
+66,463
| +31% | +$366K |
|
1596
Forestar Group
FOR
$1.48B
| $1.21M | ﹤0.01% |
68,349
+13,682
| +25% | +$256K |
|
|
EMKR
1597
DELISTED
Emcore Corp
EMKR
| $1.21M | ﹤0.01% |
32,811
-9,195
| -22% | -$440K |
|
1598
Anika Therapeutics
ANIK
$287M
| $1.21M | ﹤0.01% |
48,277
-5,378
| -10% | -$164K |
|
|
LSEA
1599
DELISTED
Landsea Homes
LSEA
| $1.21M | ﹤0.01% |
141,718
+99,418
| +235% | +$741K |
|
|
MRCC
1600
DELISTED
Monroe Capital Corp
MRCC
| $1.21M | ﹤0.01% |
112,117
+10,766
| +11% | +$117K |
|
Similar funds
John Overdeck's Q1 2022 Portfolio in Review
As of Q1 2022, John Overdeck held 4,846 positions worth $33.9B, down 28% from $46.8B the previous quarter. Its ten largest holdings account for 7.2% of the portfolio.
John Overdeck withdrew a net $11.3B in Q1 2022, closing 2,304 positions and reducing 976 holdings. Its most notable exit was Pfizer, an estimated $271M position sold in full.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, John Overdeck opened a new position in Cisco worth $223M.
- John Overdeck's largest Q1 2022 buy was Cisco: 4,001,362 shares worth $223M.
- John Overdeck added most to JPMorgan Chase in Q1 2022, an estimated $212M increase.
- John Overdeck's biggest Q1 2022 reduction was Coca-Cola, cutting an estimated $225M.
- John Overdeck fully exited Pfizer in Q1 2022, selling an estimated $271M.
- John Overdeck's ten largest holdings make up 7.2% of its $33.9B portfolio in Q1 2022.
- John Overdeck opened 656 new positions and closed 2,304 in Q1 2022.
- John Overdeck's portfolio value fell 28% quarter-over-quarter to $33.9B.
Based on Two Sigma Investments's 13F filing for Q1 2022, filed 16 May 2022.